The biochemical aftermath of anti-amyloid immunotherapy

The biochemical aftermath of anti-amyloid immunotherapy

<p>Abstract</p> <p>Background</p> <p>Active and passive immunotherapy in both amyloid-beta precursor protein (APP) transgenic mice and Alzheimer's Disease (AD) patients have resulted in remarkable reductions in amyloid plaque accumulation, although the degree of am...

Full description

Bibliographic Details
Main Authors: Nicoll James AR, Masliah Eliezer, Luehrs Dean C, Patton R Lyle, Kalback Walter M, Kokjohn Tyler A, Daugs Ian D, Maarouf Chera L, Sabbagh Marwan N, Beach Thomas G, Castaño Eduardo M, Roher Alex E
Format: Article
Language:English
Published: BMC 2010-10-01
Series:Molecular Neurodegeneration
Online Access:http://www.molecularneurodegeneration.com/content/5/1/39

Internet

http://www.molecularneurodegeneration.com/content/5/1/39

Similar Items